Respiratory Updates
前往频道在 Telegram
🟢 To stay up-to-date on pharmacotherapy and other aspects of respiratory diseases🫁 🟢 Thoracic Research Center🔬 🟢 Tehran University of Medical Sciences🎓
显示更多📈 Telegram 频道 Respiratory Updates 的分析概览
频道 Respiratory Updates (@respiratoryupdates) 英语 语言赛道中的 是活跃参与者。目前社区聚集了 19 410 名订阅者，在 医学 类别中位列第 1 179，并在 伊朗 地区排名第 17 286 位。
📊 受众指标与增长动态
自 невідомо 创建以来，项目保持高速增长，吸引了 19 410 名订阅者。
根据 26 八月, 2026 的最新数据，频道保持稳定运转。过去 30 天订阅人数变化为 460，过去 24 小时变化为 14，整体触达仍然可观。
- 认证状态： 未认证
- 互动率 (ER)： 平均受众互动率为 22.08%。内容发布后 24 小时内通常能获得 5.52% 的反应，占订阅者总量。
- 帖子覆盖： 每篇帖子平均可获得 4 284 次浏览，首日通常累积 1 070 次浏览。
- 互动与反馈： 受众积极参与，单帖平均反应数为 3。
- 主题关注点： 内容集中在 patient, guideline, edit, reader, society 等核心主题上。
📝 描述与内容策略
作者将该频道定位为表达主观观点的平台：
“🟢 To stay up-to-date on pharmacotherapy and other aspects of respiratory diseases🫁
🟢 Thoracic Research Center🔬
🟢 Tehran University of Medical Sciences🎓”
凭借高频更新（最新数据采集于 27 八月, 2026），频道始终保持新鲜度与高覆盖。分析显示受众积极互动，使其成为 医学 类别中的关键影响点。
19 410
订阅者
+1424 小时
+1117 天
+46030 天
帖子存档
19 410
Repost from Medical Guidelines 2025_2026
🔴 Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events: 2026 ACC Scientific Statement
19 410
Repost from Medical Guidelines 2025_2026
IDSA_Treatment_of_Antimicrobial_Resistant_Gram_Negative_Infections.pdf1.15 MB
19 410
Repost from Pulmonology pearls
SARCOIDOSIS: Edited by Vasileios Kouranos and Maneesh Bhargava
Recent updates in advanced pulmonary sarcoidosis
Current Opinion in Pulmonary Medicine 32(5):p 491-499, September 2026. | DOI: 10.1097/MCP.0000000000001295
19 410
Repost from Pulmonology pearls
Respiratory Medicine
Volume 255, April–May 2026, 108751
Original Research
The effect of the CareAide® mobile application in adult outpatients with asthma: A randomised controlled trial
https://doi.org/10.1016/j.rmed.2026.108751
19 410
Repost from Pulmonology pearls
Navigating evidence-based recommendations for the management of systemic sclerosis. Nat Rev Rheumatol (2026). https://doi.org/10.1038/s41584-026-01416-z
19 410
Repost from Pulmonology pearls
Review Article
Nebulized Heparin in Adults With Acute Respiratory Failure: A Meta-Analysis of Randomized Trials
the Nebulized Heparin Study Group
Critical Care Medicine 54(7):p 1755-1766, July 2026. | DOI: 10.1097/CCM.0000000000007161
19 410
Repost from Pulmonology pearls
American Journal of Kidney Diseases
Available online 3 July 2026
In Press, Journal Pre-proof
Perspective
Approach to Hyperkalemia: The Role of Diet and Pharmacological Therapies
https://doi.org/10.1053/j.ajkd.2026.03.048
19 410
Repost from N/a
آقای ۶۲ ساله با تشخیص شوک سپتیک ناشی از پنومونی، در icu . بیمار تحت رژیم درمانی با نوراپینفرین ۳۶ میکروگرم در دقیقه قرار دارد.
در آخرین بررسی:
· MAP = ۵۵ U/O = ۰.۳ cc/kh/ht · لاکتات سرم = ۴.۲ (روند نزولی ندارد) · CRT = ۴ بهترین اقدام؟
19 410
Repost from Pulmonology pearls
Feature Article
Inhaled Antibiotics to Treat Ventilator-Associated Pneumonia: A Systematic Review and Meta-Analysis
Critical Care Medicine 54(6):p 1293-1308, June 2026. | DOI: 10.1097/CCM.0000000000007072
19 410
Repost from Pulmonology pearls
The Lancet Respiratory Medicine
Available online 5 June 2026
In Press, Corrected Proof
Position Paper
Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment—an expert group consensus statement
https://doi.org/10.1016/S2213-2600(26)00094-9
19 410
Repost from Pulmonology pearls
creager_et_al_2026_2026_aha_acc_accp_acep_chest_sc_260219_225656.pdf15.12 MB
19 410
Repost from Pulmonology pearls
The Lancet Respiratory Medicine
Available online 12 February 2026
In Press, Corrected Proof
Articles
Budesonide–glycopyrronium–formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trials
KALOS and LOGOS study investigators †
https://doi.org/10.1016/S2213-2600(25)00457-6
